Condition (MeSH)
Stomach Ulcer
ClinicalTrials.gov lists 114 trials for Stomach Ulcer or a narrower condition beneath it. AstraZeneca has the most among industry and government lead sponsors, with 17.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
114 of the 114 trials are tagged with Stomach Ulcer itself; the rest are tagged with a narrower condition beneath it.
When did Stomach Ulcer trials start? (26)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 10
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 4 |
| 2024 | 4 |
| 2023 | 4 |
| 2022 | 7 |
| 2021 | 3 |
| 2020 | 4 |
| 2018 | 3 |
| 2017 | 4 |
| 2016 | 4 |
Showing 10 of 26 earlier years.
No forecast is made for this condition: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Stomach Ulcer trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 10 |
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 2/3 | 4 |
| Phase 3 | 39 |
| Phase 4 | 15 |
| Not applicable | 18 |
| Observational | 24 |
How many Stomach Ulcer trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 9 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Completed | 80 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Stomach Ulcer trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| AstraZeneca | 17 |
| Takeda | 14 |
| POZEN | 8 |
| Eisai Co., Ltd. | 5 |
| Addpharma Inc. | 2 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Stomach Ulcer? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| E3810 | 5 |
| Omeprazole 20 mg | 4 |
| Gefarnate | 2 |
| Ciprofol | 2 |
Interventions as named in the registry (11)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Nexium Pill | 13 |
| Vonoparazan | 11 |
| lansoprazole OD | 10 |
| 1: Naproxen | 5 |
| PN400 | 4 |
Showing 5 of 11 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Stomach Ulcer trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Angina pectoris | 25 | 7 |
| Pneumonia | 15 | 10 |
| Gastric cancer | 14 | 5 |
| Atrial fibrillation | 10 | 5 |
| Non-cardiac chest pain | 10 | 5 |
Showing 5 of 10 adverse events.
Which publications cover Stomach Ulcer? (188)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Evaluation of the Efficacy and Safety of a Dual Delayed-Release Formulation of 10-mg Esomeprazole in Patients with Gastric Erosions: A Multicenter, Randomized, Double-Blind, Active-Control, Phase III Study. | Gut and liver | 2025 | Yes |
| Clinical study evaluating the gastroprotective effect of carvedilol in patients with ischemic heart disease on aspirin therapy. | Inflammopharmacology | 2025 | Yes |
| Evolution of the Correa's cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication. | Journal of the Formosan Medical Association = Taiwan yi zhi | 2023 | Yes |
| Scheduled second look endoscopy after endoscopic hemostasis to patients with high risk bleeding peptic ulcers: a Randomized Controlled Trial. | Surgical endoscopy | 2022 | Yes |
| Which ICU patients need stress ulcer prophylaxis? | Cleveland Clinic journal of medicine | 2022 | Yes |
Showing 5 of 188 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.